HopeStage
Back to all studies
TerminatedNCT00955474

Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms

Medication studyAges 18–85United States
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 85 years. Other eligibility criteria apply.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateSeptember 2008
Recruitment status
Terminated
Enrollment listed in the registry
32
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 85 Years
Official registry ID
NCT00955474
Official title
Show the full official title

The Efficacy and Tolerability of Seroquel XR Combined With a Selective Serotonin Re-Uptake Inhibitor Versus Seroquel XR Monotherapy in the Acute Treatment of Major Depressive Disorder With Psychotic Features

Recruitment & locations

Terminated

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Quetiapine, escitalopram, Sertraline and Citalopram.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 85 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies